The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 09, 2019
Filed:
Sep. 13, 2018
Applicant:
Theravance Biopharma R&d Ip, Llc, South San Francisco, CA (US);
Inventors:
Mathai Mammen, Menlo Park, CA (US);
YuHua Ji, Palo Alto, CA (US);
YongQi Mu, Los Altos, CA (US);
Craig Husfeld, Redwood City, CA (US);
Li Li, Sunnyvale, CA (US);
Assignee:
THERAVANCE BIOPHARMA R&D IP, LLC, South San Francisco, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 211/62 (2006.01); A61K 31/4545 (2006.01); A61K 45/06 (2006.01); C07D 401/12 (2006.01); A61K 9/12 (2006.01); A61K 9/16 (2006.01);
U.S. Cl.
CPC ...
C07D 211/62 (2013.01); A61K 9/124 (2013.01); A61K 9/1623 (2013.01); A61K 9/1652 (2013.01); A61K 31/4545 (2013.01); A61K 45/06 (2013.01); C07D 401/12 (2013.01);
Abstract
This invention provides compounds of formula I: wherein a, b, c, d, m, n, p, s, t, W, Ar, R, R, R, R, R, R, and Rare as defined in the specification. The compounds of formula I are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.